medicalxpress - Medical artificial intelligence (AI) is often described as a way to make patient care safer by helping clinicians manage information. A new study by the Icahn School of Medicine at Mount Sinai and collaborators confronts a critical vulnerability: when a m…
#healthcare #publichealth #governmentpolicy #fda #digitalhealth #medicaldevices
Saturday, February 14, 2026, 3:21 pm / permalink 19202 / 35 stories in 24 days
medicalxpress - A new ethics policy paper from the American College of Physicians (ACP) says the term "provider" should not be used to describe physicians, and using the blanket term undermines physicians' ethical responsibility, clinical integrity, and professionalism.
#healthcare #publichealth #governmentpolicy
Saturday, February 14, 2026, 3:21 pm / permalink 19201 / 6 stories in 24 days
Mariah Taylor / beckershospitalreview - Alabama’s proposal to use robotic ultrasounds to close care gaps is being praised by national leaders but facing pushback from local physicians, KFF Health News reported Feb. 12. Alabama is facing above national average rates for infant mortality on top o…
#healthcare #publichealth #governmentpolicy #infanthealth #digitalhealth #medicaldevices
Saturday, February 14, 2026, 2:21 pm / permalink 19199 / 8 stories in 24 days
Alexis Kramer / endpoints - Eli Lilly is challenging a decision over how the FDA classified its experimental, next-gen obesity shot, in a case that could affect the ability of compounders to rival it. On Thursday, Lilly filed a notice ...
#obesity #healthcare #pharmaceuticals #elililly #weightloss #publichealth #drugdevelopment #fda #digitalhealth
Saturday, February 14, 2026, 12:21 pm / permalink 19191 / 15 stories in 24 days
Abraham Shaked / nature - Nature Medicine, Published online: 09 February 2026; doi:10.1038/s41591-025-04196-3In a study of four brain-dead human decedents, extracorporeal liver cross-circulation using genetically modified pig livers provides essential hepatic functions, supporting…
#healthcare #publichealth #governmentpolicy #biotech #fda #medicaldevices
Saturday, February 14, 2026, 10:21 am / permalink 19188 / 4 stories in 25 days
discovermagazine - Learn more about the newly approved wearable treatment that disrupts pancreatic cancer tumor growth while letting patients continue daily life at home.
#healthcare #publichealth #biotech #fda #digitalhealth #medicaldevices #oncology #pancreaticcancer
Saturday, February 14, 2026, 10:21 am / permalink 19187 / 12 stories in 25 days
medicalxpress - Throughout the past decade, Northwestern University scientists have uncovered a striking principle of vaccine design: Performance depends not only on vaccine components but also on vaccine structure. After proving this concept across multiple studies, the…
#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment
Saturday, February 14, 2026, 5:21 am / permalink 19182 / 5 stories in 25 days
Rebecca Pifer Parduhn / healthcaredive - Cigna’s layoffs follow other recent downsizing announcements from health insurers looking to cut costs during an era of heightened medical spending.
Saturday, February 14, 2026, 5:21 am / permalink 19181 / 2 stories in 25 days
Ella Jeffries / beckershospitalreview - The first FDA-cleared blood test to assess Alzheimer’s disease in primary care is now available for patients age 55 and older with symptoms of cognitive decline. The test aims to help clinicians rule out Alzheimer’s by identifying individuals unlikely to …
#healthcare #publichealth #governmentpolicy #biotech #fda
Saturday, February 14, 2026, 4:21 am / permalink 19180 / 18 stories in 25 days
medicalxpress - Scientists are testing an entirely new way to fight heart disease: a gene-editing treatment that might offer a one-time fix for high cholesterol.
#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment
Saturday, February 14, 2026, 3:21 am / permalink 19179 / 4 stories in 25 days
Frank Vinluan / medcitynews - Orna Therapeutics brings Eli Lilly an in vivo cell therapy ready for Phase 1 testing as a potential treatment for autoimmune diseases. Lilly is now the latest pharma company to use M&A to enter this growing field, following deals made in the past year by …
#healthcare #pharmaceuticals #elililly #biotech #mergersandacquisitions #corporatetakeover #drugdevelopment
Saturday, February 14, 2026, 3:21 am / permalink 19178 / 9 stories in 25 days
Reynald Castañeda / endpoints - Paul Hudson is stepping down from his post as CEO of Sanofi, and his last day will be Feb. 17. The French drugmaker's board decided not to renew Hudson's mandate on ...
#healthcare #pharmaceuticals #biotech #drugdevelopment
Saturday, February 14, 2026, 3:20 am / permalink 19177 / 3 stories in 25 days
go - Federal health officials will reassess the safety of a chemical called BHA used in foods including potato chips, cereals, frozen meals and meat products
#healthcare #publichealth #governmentpolicy #fda #foodsafety
Saturday, February 14, 2026, 1:21 am / permalink 19176 / 4 stories in 25 days
medicalxpress - Nearly all the world's 10.6 million children experiencing serious health-related suffering (SHS) live in low- and middle-income countries with little to no access to palliative care or specialized care for their illness, according to a comprehensive new r…
#healthcare #publichealth #governmentpolicy #infanthealth
Saturday, February 14, 2026, 1:21 am / permalink 19175 / 13 stories in 25 days
medicalxpress - Two major medical groups will begin reviewing vaccine safety and effectiveness after major changes at the U.S. Centers for Disease Control and Prevention (CDC) have raised alarms among experts.
#healthcare #pharmaceuticals #publichealth #governmentpolicy #cdc #vaccinesafety
Saturday, February 14, 2026, 12:22 am / permalink 19173 / 4 stories in 25 days
Katie Adams / medcitynews - Health advocate network Solace Health gained unicorn status after closing a $130 million Series C funding round. The startup’s advocates help with tasks like scheduling appointments, finding in-network providers, understanding insurance coverage and bills…
Saturday, February 14, 2026, 12:22 am / permalink 19172 / 2 stories in 25 days
Frank Vinluan / medcitynews - Infigratinib achieved statistically significant improvement in growth rate and body composition in a Phase 3 clinical trial that tested the BridgeBio Pharma drug in achondroplasia, the most common form of dwarfism. Regulatory submissions are planned for l…
#healthcare #pharmaceuticals #biotech #drugdevelopment #fda
Saturday, February 14, 2026, 12:22 am / permalink 19171 / 2 stories in 25 days
Katie Adams / medcitynews - Telepsychiatry provider Talkiatry has raised a $210 million Series D round led by Perceptive Advisors, bringing its total funding to more than $400 million. CEO Robert Krayn said the company is focused on scaling its clinician-employed model and improving…
#healthcare #publichealth #digitalhealth
Saturday, February 14, 2026, 12:22 am / permalink 19170 / 3 stories in 25 days
Nicole DeFeudis / endpoints - AbbVie is suing CMS for picking Botox for the third round of Medicare negotiations, making it the first drugmaker to challenge the upcoming cycle in court. In a lawsuit filed Wednesday in Washington, DC, AbbVie ...
#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy
Saturday, February 14, 2026, 12:22 am / permalink 19169 / 2 stories in 25 days
Judge orders Leapfrog to remove safety grades for five Florida hospitals 3 stories in 21.1 hours
Daily multivitamin slows epigenetic aging in randomized COSMOS analysis 4 stories in 40.1 hours
Engineered CAR‑T cells secreting VEGF‑neutralizing scFvs boost solid‑tumor activity 6 stories in 54.1 hours
White House briefing triggered rapid drops in acetaminophen use in ERs 2 stories in 58.1 hours
MUSC Health buys large South Carolina multispecialty practice for $111M 4 stories in 58.1 hours
Eli Lilly launches Employer Connect to broaden GLP‑1 coverage 16 stories in 83.2 hours
Analysis finds small patient group drives majority of admissions and costs 2 stories in 83.2 hours
Springing forward worsens sleep and sparks health complaints 8 stories in 87.2 hours
Cancer Grand Challenges awards five teams bold funding for cancer research 67 stories in 94.2 hours
Belzutifan combinations highlighted at ASCO GU improve RCC outcomes 3 stories in 96.2 hours
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.
Bluesky: